![]() |
|
|
M Vore, E Soliven and M Blunden
The biliary excretion of [14C]phenytoin (DPH) was examined in pregnant and nonpregnant female control rats. After administration of [14C]DPH (1 mg/kg i.v.), the bile concentration (nanomoles per milliliter) and biliary excretion (nanomoles per minute per kilogram) of the glucuronide conjugate of the major primary metabolite of DPH, 5-phenyl- 5-p-hydroxyphenyl[4-14C] hydantoin ([14C)]HPPH), was significantly decreased at 15 and 30 min in pregnant rats relative to controls. Bile flow averaged 50 and 70 microliter/min/kg in control and pregnant rats, respectively. The concentration in blood of [14C]HPPH-glucuronide was increased 2 to 6-fold in pregnant rats relative to controls. After administration of [14C]HPPH (10 mg/kg i.v.), the disappearance of [14C]HPPH from the blood, biliary excretion and bile concentration of [14C]HPPH-glucuronide were very similar in control and pregnant rats. The blood concentration of [14C]HPPH-glucuronide was elevated 2 to 6- fold in pregnant rats and the half-life was increased from 43 min in controls to 70 min in pregnant rats. Maximal bile/blood concentration ratios of [14C]HPPH-glucuronide were 630 and 300 in control and pregnant rats, respectively, indicating a decreased ability of the liver to concentrate the glucuronide in the bile in pregnancy.
This article has been cited by other articles:
![]() |
B. R. Jones, W. Li, J. Cao, T. A. Hoffman, P. M. Gerk, and M. Vore The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2) Mol. Pharmacol., September 1, 2005; 68(3): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, B. Stieger, P. J. Meier, and M. Vore Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kim, L. M. Winn, T. Parman, and P. G. Wells UDP-Glucuronosyltransferase-mediated Protection Against In Vitro DNA Oxidation and Micronucleus Formation Initiated by Phenytoin and Its Embryotoxic Metabolite 5-(p-Hydroxyphenyl)-5-phenylhydantoin J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 200 - 209. [Abstract] [Full Text] |
||||